Abstract

The activity profile of a protein tyrosine phosphatase (PTP) inhibitor and redox thiol oxidant, nitropropenyl benzodioxole (NPBD), was investigated across a broad range of bacterial species. In vitro assays assessed inhibitory and lethal activity patterns, the induction of drug variants on long term exposure, the inhibitory interactions of NPBD with antibiotics, and the effect of plasma proteins and redox thiols on activity. A literature review indicates the complexity of PTP and redox signaling and suggests likely metabolic targets. NPBD was broadly bactericidal to pathogens of the skin, respiratory, urogenital and intestinal tracts. It was effective against antibiotic resistant strains and slowly replicating and dormant cells. NPBD did not induce resistant or drug-tolerant phenotypes and showed low cross reactivity with antibiotics in synergy assays. Binding to plasma proteins indicated lowered in-vitro bioavailability and reduction of bactericidal activity in the presence of thiols confirmed the contribution of thiol oxidation and oxidative stress to lethality. This report presents a broad evaluation of the antibacterial effect of PTP inhibition and redox thiol oxidation, illustrates the functional diversity of bacterial PTPs and redox thiols, and supports their consideration as novel targets for antimicrobial drug development. NPBD is a dual mechanism agent with an activity profile which supports consideration of tyrosine phosphatases and bacterial antioxidant systems as promising targets for drug development.

Highlights

  • Cellular signal transduction networks sense and transmit internal and external signals, resulting in coordinated responses to stimuli

  • Bacterial Protein tyrosine kinases (PTKs) and protein tyrosine phosphatase (PTP) have diversified structurally and functionally from those in eukaryotes, performing differing and often unique functions making them suitable targets for selective inhibition [3]

  • PTPs positively and negatively regulate components of signal pathways and their inhibition could result in desirable or undesirable physiological effects, which might differ between species

Read more

Summary

Introduction

Cellular signal transduction networks sense and transmit internal and external signals, resulting in coordinated responses to stimuli. PTPs positively and negatively regulate components of signal pathways and their inhibition could result in desirable or undesirable physiological effects, which might differ between species They are present at very low levels and are transiently and variably active, depending on the environmental context, making identification of functions difficult [10]. Nitroethenyl benzene (NEB), nitropropenyl benzene (NPB), nitroethenyl benzodioxole and NPBD are reversible inhibitors of enzymatic activity of PTP1B, SHP1, Yop and CD45 with differing levels of inhibition of enzymatic function ([11,12,13], Table S2). These compounds compete with PTyr substrate proteins for binding to PTP active sites. NPBD (BDM-I), a broadly active NAB analogue, is in preclinical development as an antimicrobial drug for human

Antibacterial of NPBD against therapeutic uses byactivity
Bacterial Species
Thiol Reduction of NPBD Decreases Antimicrobial Activity
Bactericidal rates for NPBD againstRMIT3131
NPBD kills cells
Casamino
Materials and Methods
MIC and MBC Broth Microdilution Assays
Time-Kill Assays
NPBD Interaction with Antibiotics
Development of Resistance on Continuous Exposure to NPBD
Patents
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call